Skip to content

13F-HR filed by RTW INVESTMENTS, LP

RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-15, with 32 holding rows worth $265,666,000.

Accession
0001493152-17-001592
Filed
2017-02-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 32 entries on the cover page, a total value of $265,666,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $265,662,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVEXIS INC05366U100COM849,043$40,525,000thousands by filing date
Bristol-Myers Squibb Company110122108COM565,888$33,070,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock789,208$29,548,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock4,078,895$25,819,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 21,086,037$19,038,000thousands by filing date
AGENUS INC00847G705COM NEW4,210,264$17,346,000thousands by filing date
MEDICINES CO584688105COM374,263$12,702,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM997,166$10,879,000thousands by filing date
INCYTE CORP COM45337C102Stock86,757$8,699,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS543,287$8,122,000thousands by filing date
UNITED STATES OIL FUND LP91232N108UNITS675,000$7,911,000thousands by filing date
BLUEBIRD BIO INC09609G100COM122,576$7,563,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM2,043,216$5,884,000thousands by filing date
MASIMO CORP COM574795100Stock80,900$5,453,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock372,624$5,291,000thousands by filing date
CORIUM INTL INC21887L107COM1,101,045$4,470,000thousands by filing date
REGENXBIO INC75901B107COM239,789$4,448,000thousands by filing date
VIVEVE MED INC92852W204COM NEW839,666$4,324,000thousands by filing date
TACTILE SYSTEMS TECHNOLOGY I87357P100COMMON STOCK248,762$4,082,000thousands by filing date
INVUITY INC46187J205COM NEW454,900$2,616,000thousands by filing date
OMEROS CORP682143102COM259,039$2,570,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM286,285$1,182,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM239,662$848,000thousands by filing date
SENSUS HEALTHCARE INC81728J109COM122,803$645,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM129,697$616,000thousands by filing date
BIOPHARMX CORP09072X101COM1,273,128$476,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM25,963$375,000thousands by filing date
NATERA INC COM632307104Stock31,693$371,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock20,000$365,000thousands by filing date
MANNKIND CORP56400P201COM438,500$279,000thousands by filing dateput
Sensus Healthcare, Inc @6.75 681728J117warrants155,000$78,000thousands by filing date
NIVALIS THERAPEUTICS INC65481J109COM30,000$67,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-17-001592this filing2017-02-15acceptance time not in the bulk data set